Skip to main content
Clinical Trials/NCT07461870
NCT07461870
Active, not recruiting
Not Applicable

The Mediterranean Diet Based on Local Foods for Obese Patients: A Study of Anthropometric Parameters, Inflammatory Markers, and Gut Microbiota

Indonesia University1 site in 1 country54 target enrollmentStarted: December 9, 2025Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
54
Locations
1
Primary Endpoint
The implementation of a locally adapted Mediterranean has the potential to improve anthropometric outcomes profiles in obese.

Overview

Brief Summary

The goal of this clinical trial is to examine the efficacy of a Mediterranean diet based on local Indonesian foods on alterations in gut microbiota, body composition, and metabolic biomarkers in obese subjects. The main questions it aims to answer are:

Dose Mediterranean diet modification based on local food ingredients can result in greater weight loss, greater reductions in inflammatory markers, improve gut microbiota diversity compared to a balanced low-calorie diet in obese patients?

Researchers will compare Mediterranean diet modification based on local food to low calorie diet.

Participant will:

  • Participants received a low-calorie diet of approximately 1.500 kcal/day according to their randomized group assignments, consisting of breakfast, lunch, dinner, and snacks. Both groups will receive dietary education and physical activity guidance tailored to their weight loss needs.
  • Participants were instructed to complete a food intake record and report their consumption to the researchers using intake forms and photographs of the food packaging. Weekly meetings were held via Zoom to evaluate dietary compliance.
  • Blood samples and fecal specimens were collected at baseline (week 0) and at week 4 of the study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Women who were obese, as defined by a BMI of at least
  • Aged 18-50 years
  • Subjects with a non-shift work schedule
  • Willing to follow the research procedures and sign the informed consent form.

Exclusion Criteria

  • Subjects with a history of type 2 diabetes, kidney disease, liver disease, or thyroid disorders, as indicated by medical history or medical records.
  • Contraindications for the MF-BIA examination include the use of pacemakers or implants and a history of amputation.
  • Pregnant or within 40 days of childbirth
  • Adults with edema
  • Taking medications with hyperglycemic effects, such as beta-blockers, thiazides, corticosteroids, calcineurin inhibitors, anti-dyslipidemic medications (e.g., statins, fibrates, niacin, and bile acid sequestrants), or antibiotics.
  • History of food allergies

Arms & Interventions

Low calorie diet

Active Comparator

In the control group, Participants received a low calorie diet providing approximately 1,500 kcal/day, the diet provided 50-54% carbohydrates, 25-30% fat (SFA < 12%, MUFA 8-12%, PUFA 5-8%), and 19-20% protein.

Intervention: Locally Adapted Mediterranean Diet (Other)

Locally Adapted Mediterranean Diet

Experimental

In the interventional group, participants received a locally adapted Mediterranean diet providing approximately 1,500 kcal/day, with a macronutrient distribution of 50% carbohydrates, 30-34% fat (saturated fatty acids ≤ 8%, monounsaturated fatty acids 15-20%, polyunsaturated fatty acids 5-10%), and 17-20% protein.

Intervention: Low calorie diet (Other)

Outcomes

Primary Outcomes

The implementation of a locally adapted Mediterranean has the potential to improve anthropometric outcomes profiles in obese.

Time Frame: The data were collected at baseline (week 0) and at week 4 of the study.

Title of the research is The Mediterranean Diet Based on Local Foods for Obese Patients: A Study of Anthropometric Parameters, Inflammatory Markers, and Gut Microbiota. Based on PRS review of each outcome the findings are described as follows: Anthropometric outcomes (ratio data scale): 1. Body mass index (BMI) will be calculated from weight (kilograms) and height (meters). Divide weight in kilograms (kilograms) by height in meters squared (meters²) expressed as kg/m². 2. Waist-to-hip ratio (WHR) is calculated by dividing waist circumference (centimeters) by hip circumference (centimeters) and expressed as cm. (WHR = Waist / Hip)

Secondary Outcomes

  • To determine the characteristics of the research subjects based on age.(The data were collected at baseline (week 0))
  • To determine the characteristics of the research subjects based on underlying disease.(The data were collected at baseline (week 0))
  • To determine the characteristics of the research subjects based on nutritional status.(The data were collected at baseline (week 0))
  • To determine the characteristics of the research subjects based on body composition.(The data were collected at baseline (week 0)])
  • To determine the characteristics of the research subjects based on intake patterns.(The data were collected at baseline (week 0))
  • To determine the characteristics of the research subjects based on physical activity.(The data were collected at baseline (week 0))
  • To determine the energy, protein, fat, and carbohydrate intake of research subjects before and after diet administration.(the data were collected at baseline (week 0) and at week 4 of the study.)
  • To determine the differences in the mean anthropometry of the research subjects in each group.(The data were collected at baseline (week 0) and at week 4 of the study.)
  • To determine the differences the mean in nutritional status of the research subjects in each group.(The data were collected at baseline (week 0) and at week 4 of the study.)
  • To determine the differences in the mean body composition of the research subjects in each group.(The data were collected at baseline (week 0) and at week 4 of the study.)
  • To determine changes and mean in IL-6 levels in research subjects before and after diet administration.(the data were collected at baseline (week 0) and at week 4 of the study.)
  • To determine changes and mean in I-FABP levels in research subjects before and after diet administration.(the data were collected at baseline (week 0) and at week 4 of the study.)
  • To determine changes and mean in TyG index levels in research subjects before and after diet administration.(the data were collected at baseline (week 0) and at week 4 of the study.)
  • To determine the effect of a locally adapted Mediterranean diet (intervention) and low calorie diet (control) on improving gut microbiota diversity in obese patients.(the data were collected at baseline (week 0) and at week 4 of the study.)
  • To determine the effect of a locally adapted Mediterranean diet (intervention) and low calorie diet (control) on improving metabolomic profile in obese patients.(the data were collected at baseline (week 0) and at week 4 of the study.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Diyah Eka Andayani

Principle Investigator, Clinical Nutrition Specialist

Indonesia University

Study Sites (1)

Loading locations...

Similar Trials